The long duration, in vivo, inhibition of prostaglandin synthetase by 2-methyl-8- cis-12- trans-14- cis-eicosatrienoic acid

Competitive inhibition of prostaglandin synthetase by 8- cis-12- trans-14- cis-eicosatrienoic acid has been reported to occur in vitro. No in vivo effects were observed, possibly due to rapid metabolic degradation of this fatty acid by β-oxidation. The present study involved the evaluation of this compound in vivo, and the preparation and evaluation in vivo of its α and β methyl-substituted analogs which retain the carbon skeleton of the parent compound, and which might be expected to be resistant to β- oxidation. Using a newly developed radioimmunoassay for the total urinary metabolites of prostaglandin E, data were obtained that indicates that both the parent compound and its 2-methyl analog are prostaglandin synthetase inhibitors in vivo. The 2-methyl analog exhibited an unusually long duration of activity as compared to both indomethacin and the parent compound. The lengthened duration of action of the 2-methyl analog may be explained both by its possible resistance to β-oxidation, and to possible alteration in rates of either fatty acid transport, or incorporation/release from triglycerides (acylation/deacylation of triglycerides).